Ultima-MYO 1mg Ultima Peptides
| Features | |
| Active substance | Human Growth Hormone |
| Also known as | Myostatin blocking peptides, myostatin inhibitors |
| Blood pressure | Impact unknown, not well studied |
| Chemical name | Not Specifically Defined |
| Dosage (medical) | Not established, as usage and safety in medical contexts are not well-defined |
| Dosage (sports) | Not established, highly variable depending on source and formulation |
| Effects | Potential increase in muscle mass and strength, decrease in fat mass |
| Formula | Variable, dependent on specific peptide sequence |
| Half-life | Generally short, ranging from a few minutes to a few hours depending on the peptide |
| Hepatotoxicity | Unknown, but likely low given the nature of peptides |
| Lab Test | Specific tests for detection in sports not widely available |
| Main action | Inhibition of myostatin |
| Side effects | May include potential disturbances in muscle fiber function, risk of tendon damage, and other unknown long-term effects |
| Storage conditions | Typically requires refrigeration |
| Substance class | Peptide |
| Trade name | Various, often marketed under various supplement or research chemical labels |
| Use in sports | Primarily for attempted enhancement of muscle growth and performance |
| WAREHOUSE | International Warehouse 3 |
| Water Retention | Minimal to none |
| Manufacturer | Ultima Peptides |